Alpha Tau Medical Ltd. (DRTSW)
- Previous Close
0.1800 - Open
0.2096 - Bid --
- Ask --
- Day's Range
0.2096 - 0.2098 - 52 Week Range
0.2096 - 0.2098 - Volume
3,316 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.
www.alphatau.comRecent News: DRTSW
Compare To: DRTSW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DRTSW
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-19.60%
Return on Equity (ttm)
-30.67%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-29.16M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
81.79M
Total Debt/Equity (mrq)
15.72%
Levered Free Cash Flow (ttm)
-19.4M
Company Insights: DRTSW
DRTSW does not have Company Insights